- Filed
- May 29, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · May 21, 2025 | 679.81M sh |
| Stock Repurchased | FY 2024 · Mar 31, 2025 | $1.29B |
| Stock Repurchased | FY 2024 · Mar 31, 2024 | $0 |
| Stock Repurchased | FY 2024 · Mar 31, 2023 | $0 |
| Cash And Equivalents restated | FY 2024 · Mar 31, 2024 | $6.49B |
| Stockholders Equity | FY 2024 · Mar 31, 2024 | $5.97B |
| Current Liabilities | FY 2024 · Mar 31, 2024 | $266.76M |
| Total Liabilities | FY 2024 · Mar 31, 2024 | $773.95M |
| Current Assets | FY 2024 · Mar 31, 2024 | $6.73B |
| Total Assets | FY 2024 · Mar 31, 2024 | $7.22B |
| Shares Diluted | FY 2024 · Mar 31, 2023 | 712.79M sh |
| Capex | FY 2024 · Mar 31, 2023 | $12.69M |
| Operating Cash Flow | FY 2024 · Mar 31, 2023 | −$843.39M |
| Eps Diluted | FY 2024 · Mar 31, 2023 | −$1.42 |
| Eps Basic | FY 2024 · Mar 31, 2023 | −$1.42 |
| Rd Expense restated | FY 2024 · Mar 31, 2023 | $454.06M |
| Net Income | FY 2024 · Mar 31, 2023 | −$1.01B |
| Operating Income restated | FY 2024 · Mar 31, 2023 | −$906.76M |
| Revenue restated | FY 2024 · Mar 31, 2023 | $31.53M |